Three Units of Account: Statutory Architecture, Home Health Table 8, and the CY 2026 Payment Structure
Financial modeling for single-use, disposable Negative Pressure Wound Therapy (dNPWT) systems requires strict separation between Home Health Prospective Payment System billing, Physician Fee Schedule (PFS) office reimbursement, and DMEPOS capped rental allowances. Commercial projections that treat the CY 2026 Home Health Table 8 device-only rate ($282.10) and the physician office payment for CPT 97607 ($367.41) as interchangeable reimbursement amounts fail to account for how federal statutes separate professional service time from device acquisition costs.
| Billing Code / Base Rate | Care Setting & Payment Mechanism | CY 2026 Amount (USD) | Administrative Unit of Account & Statutory Interpretation |
|---|---|---|---|
| HCPCS A9272 | Home Health Agency (TOB 032x) | $282.10 | Separate payment per complete furnished system; nursing/therapy visits paid under HH PPS, normally adjusted 30-day payment or applicable LUPA per-visit rules. Deductible and coinsurance apply to A9272; $282.10 is a gross benchmark before cost sharing and claim adjustments. |
| CPT 97607 | Physician Office (Non-Facility POS 11) | $367.41 | Total non-facility application payment per session; total wound surface area <=50 cm²; bundles clinical labor, standard supplies, and SA131 kit supply input ($263.25). |
| CPT 97607 | Facility setting | $18.70 | Physician professional payment only; SA131 supply input drops to zero with facility payment assessed under its applicable rules. |
| CPT 97608 | Physician Office (Non-Facility POS 11) | $396.80 | Total non-facility application payment per session; total wound surface area >50 cm²; bundles clinical staff time (50.5 min), standard supplies, and SA131 kit ($263.25). |
| CPT 97608 | Facility setting | $21.71 | Physician professional payment only in facility setting; facility payment follows its applicable setting rules. |
| CMS SA131 | PFS Direct Practice Expense Input | $263.25 | Direct supply input price used to derive CPT 97607/97608 PE RVUs; not a separately billable procedure or product fee. |
| E2402 RR (Non-Rural) | DMEPOS Capped Rental (Months 1–3) | $829.21 | Contiguous non-rural median monthly pump rental allowance (range $748.28–$881.94); 10% of recognized purchase price. |
| E2402 RR (Non-Rural) | DMEPOS Capped Rental (Months 4–13) | $621.91 | Contiguous non-rural median monthly rental allowance after 25% statutory step-down under 42 CFR § 414.229(b)(2). |
| E2402 RR (Rural) | DMEPOS Capped Rental (Months 1–3) | $1,504.41 | Uniform contiguous rural monthly pump rental allowance for initial three rental months. |
| E2402 RR (Rural) | DMEPOS Capped Rental (Months 4–13) | $1,128.31 | Uniform contiguous rural monthly pump rental allowance after 25% statutory step-down (Months 4 through 13). |
| HH PPS Standard Base | Home Health Agency (30-Day Period) | $2,038.22 | National unadjusted 30-day base for quality-reporting agencies; case-mix/wage/other adjustments apply, with separate LUPA per-visit rules where applicable. |
Payment amounts represent distinct administrative units (device-only payment, total non-facility application payment per session, monthly equipment rental, or bundled 30-day episode) and cannot be compared directly as equipment prices.
- Amounts reflect national unadjusted fee schedule calculations or component medians; actual provider reimbursement depends on geographic wage indices, patient eligibility, and medical review. HH visits normally use adjusted 30-day payment; LUPA per-visit rules apply where applicable. Deductible and coinsurance apply to A9272 on TOB 032x (MM13244).
Source: CMS Transmittal 13488 / CR 14304 (CY 2026 HH PPS Table 8), CY 2026 PFS Final Rule (CMS-1832-F Relative Value and Direct PE Files), and October 2026 DMEPOS Fee Schedule (DME26-D) — VEMERIX analysis, accessed October 2026.
Statutory Evolution from CAA 2016 § 504 to CAA 2023 § 4136: The $282.10 Device-Only Home Health Rate
The statutory framework governing disposable NPWT reimbursement in home health originated in Section 504 of the Consolidated Appropriations Act, 2016 (Pub. L. 114-113), which enacted Section 1834(s) of the Social Security Act effective January 1, 2017 2 11. Under CMS implementing instructions published in Medicare Learning Network (MLN) Matters article SE17027, Medicare initially required Home Health Agencies (HHAs) to furnish dNPWT to homebound beneficiaries using a split-billing mechanism 11. The agency billed professional wound care visits on Type of Bill (TOB) 034x using CPT 97607 or 97608, receiving payment tied to the Hospital Outpatient Prospective Payment System (OPPS) rate 11. That OPPS-linked payment bundled the physical disposable device together with the skilled nursing visit. However, CMS billing instructions required the agency to carve out the services associated with furnishing that complete new system from the overarching home health episode claim on TOB 032x 11. Follow-up wound care without furnishing a new system remained distinct.
Congress subsequently restructured Section 1834(s) through Division FF, Section 4136 of the Consolidated Appropriations Act, 2023 (Pub. L. 117-328), effective January 1, 2024 1 2. Under Section 4136 and CMS implementing instructions in Transmittal R12291BP (Change Request 13244, MLN Matters MM13244), the billing and payment mechanism for dNPWT was bifurcated 1 12:
- Skilled Nursing Time Re-Integrated into the 30-Day Period Claim: Effective January 1, 2024, HHAs ceased billing CPT 97607 and 97608 on TOB 034x 1 12. Skilled nursing and therapy visits involving disposable NPWT are recorded on the home health claim (TOB 032x) and paid under HH PPS, normally through the adjusted 30-day payment or the applicable LUPA per-visit rules 1 12.
- Creation of Separate Device-Only Payment (HCPCS A9272 on TOB 032x): Under Social Security Act § 1834(s)(2), an applicable disposable NPWT device is defined as "an integrated system comprised of a non-manual vacuum pump, a receptacle for collecting exudate, and dressings" 2 11. When an HHA furnishes this equipment, the agency bills HCPCS A9272 (Wound suction, disposable, includes dressing, all accessories and components, any type, each) on TOB 032x to receive a separate payment covering the physical hardware 1 12.
- Statutory annual update: For CY 2024, Section 1834(s)(3)(A)(ii) uses the supply price in the January 1, 2022 PFS for CPT 97607/97608, updated by the specified CPI-U increase and productivity adjustment. Under (3)(A)(iii), update the preceding year's payment amount for each subsequent year using the adjustment defined in (3)(B). Thus the 2026 calculation begins with the 2025 payment, rather than resetting to the original supply price every year 1 2.
In CMS Pub 100-04 Medicare Claims Processing Manual, Transmittal 13488 (Change Request 14304, issued November 20, 2025, re-communicated December 10, 2025, and effective January 1, 2026), CMS issued the official CY 2026 payment tables implementing the Home Health Prospective Payment System Final Rule (CMS-1828-F, 90 FR 55342) 1 13:
- Table 8 (CY 2026 dNPWT Device Rate): Starting from the CY 2025 rate of $276.57, CMS applied a net update factor of 1.020 (a 2.7 percent increase in the June 2025 12-month CPI-U minus a 0.7 percent MFP adjustment), establishing the CY 2026 separate device payment for HCPCS A9272 at exactly $282.10 1.
- Tables 1 and 2 (CY 2026 30-Day Base Period Payments): Table 1 establishes the national standardized 30-day period payment for agencies submitting required quality reporting data at $2,038.22, incorporating a permanent behavioral adjustment of 0.98977 (-1.023 percent) and a temporary adjustment of 0.97000 (-3.0 percent) 1. Table 2 establishes the payment for non-reporting agencies at $1,998.41 1.
- Table 3 (Per-Visit LUPA Rates): For low-utilization payment adjustment (LUPA) episodes where visits fall below the case-mix clinical threshold, Table 3 establishes national per-visit rates for quality-reporting agencies: $176.96 for Skilled Nursing, $193.42 for Physical Therapy, $194.74 for Occupational Therapy, $210.25 for Speech-Language Pathology, $283.64 for Medical Social Services, and $80.12 for Home Health Aide services 1.
The home-health arrangement pays a separate device-only amount under A9272, with visits paid through the HH PPS claim. As a hypothetical arithmetic example, three separately furnished and otherwise billable complete disposable systems would yield 3 × $282.10 = $846.30 before applicable deductible, coinsurance and other claim adjustments. MACs apply deductible and coinsurance to A9272 on TOB 032x 12. Actual units and payment require the covered furnishing and claim rules; the national 30-day base amount is $2,038.22 before case-mix, wage and other adjustments 1.
Deconstructing the CY 2026 Physician Fee Schedule: Direct Practice Expense Inputs and SA131 Valuation
Under the CY 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) Relative Value File and Direct Practice Expense Input public use files, payments for disposable NPWT application in physician offices differ from home health and facility settings 3. While home health separates device cost from clinical labor across two billing streams, the Physician Fee Schedule packages device acquisition, clinical labor, overhead supplies, and professional work into a single non-facility payment.
The October RVU26D release is the source for the following components 14.
Under the CY 2026 non-Qualifying APM Participant (non-QP) conversion factor of $33.4009 (and the Qualifying APM Participant conversion factor of $33.5675), total office reimbursement is structured around Direct Practice Expense (PE) inputs 3:
- Disposable Application of 50 sq cm or Less (CPT 97607): In a non-facility office setting (Place of Service 11), the physician practice purchases and furnishes the disposable kit 3. Direct PE inputs total $277.68, comprising 1.0 unit of CMS Supply Code SA131 (kit, negative pressure wound therapy, disposable) at $263.25, standard clinical supplies ($3.26 across sterile drape-towel SB019, gloves SB022/SB024, Chux SB044, gauze SG056, and surgical tape SG079), clinical labor ($10.80 for 36 minutes of blended clinical staff time), and direct medical equipment usage ($0.37 for 20 minutes of surgical light and examination table time) 3. Within direct inputs, SA131 accounts for 94.80 percent ($263.25 / $277.68) 3. Following the allocation of indirect practice expenses, the non-facility PE RVU is established at 10.54, which, when combined with Work (0.40 RVU) and Malpractice (0.06 RVU), yields a total non-facility RVU of 11.00 and an unadjusted national payment of $367.41 (or $369.24 for QP clinicians) 3. Within this total payment, the practice expense component represents 95.82 percent (10.54 / 11.00) of the total RVU 3.
- Disposable Application Greater than 50 sq cm (CPT 97608): For larger wounds, direct non-facility inputs total $282.15, comprising SA131 at $263.25 (accounting for 93.30 percent of direct inputs), standard supplies ($3.26), clinical labor ($15.12 for 50.5 minutes of staff time), and equipment ($0.52 for 28 minutes) 3. Combined with Work (0.45 RVU) and Malpractice (0.08 RVU), the non-facility PE RVU of 11.35 brings the total RVU to 11.88, yielding an office payment of $396.80 (or $398.78 for QP clinicians) 3. Practice expense constitutes 95.54 percent (11.35 / 11.88) of total RVUs 3.
- The Facility Practice Expense Differential: In facility settings (the facility category in the PFS file), the facility purchases and furnishes the disposable kit; consequently, direct supply inputs for SA131 in the physician fee file drop to zero (quantity 0.0) 3. As a result, the physician's facility PE RVU drops to 0.10 for CPT 97607 and 0.12 for CPT 97608, reducing physician professional payments to $18.70 (0.56 total RVU) and $21.71 (0.65 total RVU) respectively 3.
- Durable NPWT Professional Application (CPT 97605 and 97606): When a clinician evaluates and dresses a wound managed with a durable electric pump (E2402), eligible home-use durable equipment and supplies may be billed separately under the DME benefit, subject to its coverage rules. A facility professional fee alone establishes no separate DME equipment-payment entitlement 15 16. The physician fee schedule direct PE file contains only $2.96 in basic wound supplies plus clinical staff labor and equipment time 3. Total national non-facility payment is $42.09 (1.26 RVU) for CPT 97605 and $50.44 (1.51 RVU) for CPT 97606, dropping in facility settings to $21.04 (0.63 RVU) and $23.05 (0.69 RVU) 3.
The 50 cm² division concerns total wound surface area for the session, not a separate limit for each wound. The figures below are total application payments per session; the PE column is only the practice-expense component 17.
| CPT Code | Clinical Description | Setting & Jurisdiction | Work RVU | PE RVU | MP RVU | Total RVU | CY 2026 Non-QP Payment | SA131 kit input (other supplies separate) | Kit Share of Direct PE |
|---|---|---|---|---|---|---|---|---|---|
| 97605 | NPWT application, durable, wound <=50 sq cm | Non-Facility (Office) | 0.54 | 0.71 | 0.01 | 1.26 | $42.09 | Absent; other wound supplies $2.96 (non-facility) | 0.00% (Billed to DMEPOS) |
| 97605 | NPWT application, durable, wound <=50 sq cm | Facility (facility designation) | 0.54 | 0.08 | 0.01 | 0.63 | $21.04 | Absent | 0.00% |
| 97606 | NPWT application, durable, wound >50 sq cm | Non-Facility (Office) | 0.59 | 0.91 | 0.01 | 1.51 | $50.44 | Absent; other wound supplies $2.96 (non-facility) | 0.00% (Billed to DMEPOS) |
| 97606 | NPWT application, durable, wound >50 sq cm | Facility (facility designation) | 0.59 | 0.09 | 0.01 | 0.69 | $23.05 | Absent | 0.00% |
| 97607 | NPWT application, disposable, wound <=50 sq cm | Non-Facility (Office) | 0.40 | 10.54 | 0.06 | 11.00 | $367.41 | $263.25 (CMS SA131 Kit) | 94.80% ($263.25 / $277.68) |
| 97607 | NPWT application, disposable, wound <=50 sq cm | Facility (facility designation) | 0.40 | 0.10 | 0.06 | 0.56 | $18.70 | $0.00 (Facility furnishes) | 0.00% |
| 97608 | NPWT application, disposable, wound >50 sq cm | Non-Facility (Office) | 0.45 | 11.35 | 0.08 | 11.88 | $396.80 | $263.25 (CMS SA131 Kit) | 93.30% ($263.25 / $282.15) |
| 97608 | NPWT application, disposable, wound >50 sq cm | Facility (facility designation) | 0.45 | 0.12 | 0.08 | 0.65 | $21.71 | $0.00 (Facility furnishes) | 0.00% |
Longitudinal Medicare Part B Utilization Dynamics: 2015–2024 Utilization Trajectories and Care-Setting Shifts
Longitudinal analysis of the CMS Medicare Part B Physician & Other Practitioners by Geography and Service dataset across calendar years 2015 through 2024 describes changes in billed application-code activity in facility and non-facility categories 18.
View chart data
| Category | CPT 97605 (Durable NPWT <=50 sq cm) | CPT 97606 (Durable NPWT >50 sq cm) | CPT 97607 (Disposable NPWT <=50 sq cm) | CPT 97608 (Disposable NPWT >50 sq cm) |
|---|---|---|---|---|
| 2015 | 46085 | 14300 | 1219 | 421 |
| 2016 | 47288 | 14297 | 2488 | 693 |
| 2017 | 50689 | 15977 | 4013 | 899 |
| 2018 | 53069 | 16133 | 5180 | 1160 |
| 2019 | 53205 | 16877 | 6036 | 1246 |
| 2020 | 48723 | 17409 | 6203 | 1417 |
| 2021 | 45200 | 17257 | 8385 | 1522 |
| 2022 | 40592 | 14412 | 8556 | 1535 |
| 2023 | 39330 | 14416 | 10803 | 1866 |
| 2024 | 38686 | 14359 | 11815 | 2361 |
Disposable 97607 services rose from 1,219 (2015) to 11,815 (2024) while durable 97605 fell from a 2019 peak of 53,205 to 38,686; the series counts billed services, not patients or causes.
- Amounts represent national Part B fee-for-service billed utilization; does not reflect Medicare Advantage claims, unique patient episodes, or clinical efficacy.
Source: CMS Medicare Part B Physician & Other Practitioners by Geography and Service Dataset (2015–2024) — VEMERIX analysis, accessed October 2026.
When CPT 97607 and 97608 were introduced in 2015 to distinguish single-use disposable systems from durable pump applications (CPT 97605 and 97606), CMS initially placed the new codes under contractor pricing without national practice expense supply valuation 17. Utilization unfolded across two distinct regulatory eras 18:
- Earlier observed payment series (2015–2019): From 2015 to 2019, national Medicare Part B average payment per service for non-facility CPT 97607 ranged between $27.64 (2016) and $37.37 (2019)—barely exceeding facility payments ($20.92 to $21.47) and with no acquisition-cost conclusion available from this utilization dataset 18. During that period, non-facility volume was lower than facility volume, recording only 143 services nationwide in 2015 and 744 in 2019 18. Most early disposable NPWT applications took place in facility settings, which billed 1,076 facility services in 2015 and 5,292 in 2019 18. Nationally, combined (non-facility and facility) CPT 97607 volume totaled 1,219 services in 2015 ($27,591.32 estimated expenditure) and 6,036 in 2019 ($139,858.48 estimated expenditure) 18. Over the same period, larger-wound CPT 97608 grew from 421 services in 2015 to 1,246 in 2019, while non-facility services grew from 39 to 131 18.
- National Practice-Expense Repricing Era (2020–2024): In the CY 2020 Physician Fee Schedule Final Rule (CMS-1715-F, 84 FR 62568), CMS established national valuation for CPT 97607 and 97608, finalizing the SA131 input at $208 for the non-facility direct-PE valuation 17. Average Medicare payments for non-facility CPT 97607 rose from $37.37 in 2019 to $218.52 in 2020, $258.74 in 2021, $290.64 in 2022, and $258.00 in 2024 18. Following this regulatory change, non-facility CPT 97607 volume expanded from 744 services in 2019 to 1,606 in 2020, 3,356 in 2021, 4,167 in 2022, 5,246 in 2023, and 5,823 in 2024 18. Total national CPT 97607 volume reached 11,815 services in 2024, generating $1,600,423.12 in estimated national payment—an 869.24 percent volume increase over 2015 (1,219 services) 18. CPT 97608 experienced a parallel expansion, growing 460.81 percent from 421 services in 2015 ($10,707.48 estimated expenditure) to 2,361 services in 2024 ($164,769.19 estimated expenditure), with non-facility volume climbing from 39 to 501 services 18.
Durable-code activity also changed: CPT 97605 fell from 53,205 services in 2019 to 38,686 in 2024; CPT 97606 recorded 14,359 services in 2024. These are billed-service series, not unique patients or measured clinical migration. The non-facility/facility distinction is the dataset's category; it does not establish a specific place-of-service code for every record 18.
Estimated payments in the series are services multiplied by average Medicare payment, distinct from allowed amounts or total episode costs. Disposable application codes include a kit in the relevant non-facility PFS bundle; durable application-code payments exclude separately billed DMEPOS equipment and supplies. A cross-modality comparison of these application-code totals would therefore compare unequal bundles. The series does not measure causes of volume changes or total treatment spending 18.
DMEPOS Fee Schedule Architecture: Capped Rental Step-Downs, File Conventions, and the E2402 vs. E2403 Boundary
Capped Rental Step-Down Dynamics and State-Level Durable NPWT Monthly Benchmarks
Durable NPWT electric pumps are classified under the Capped Rental (CR) payment category pursuant to Section 1834(a)(7) of the Social Security Act and 42 CFR § 414.229 (Other durable medical equipment—capped rental items) 4 19. Financial models that project static monthly rental revenue over an extended episode fail to account for statutory payment reductions:
- The 75 Percent Rental Step-Down Rule (42 CFR § 414.229(b)(2)): Under federal regulations, the monthly rental payment for an item in the capped rental category equals 10 percent of the recognized purchase price for the initial three rental months (months 1 through 3), stepping down to 7.5 percent of the purchase price (a 25 percent reduction from the initial monthly fee) for rental months 4 through 13 4. Capped-rental mechanics do not establish a 13-month NPWT coverage entitlement; the applicable LCD coverage conditions and duration still control. After 13 continuous rental months, ownership of the equipment transfers to the beneficiary pursuant to 42 CFR § 414.229(f)(2), and rental payments cease entirely 4.
- Durable Pump Pricing (HCPCS E2402 RR): In the October 2026 DMEPOS Fee Schedule (DME26-D), contiguous non-rural monthly rental allowances for E2402 RR range from $748.28 to $881.94, with a median of $829.21 and a mean of $818.58 19. This $829.21 median applies to rental months 1 through 3; under 42 CFR § 414.229(b)(2), the allowance steps down to $621.91 per month (0.75 × $829.21) for rental months 4 through 13 4 19. Across all contiguous non-rural states, months 4 through 13 allowances range from $561.21 to $661.46 (mean $613.94) 4 19. In contiguous rural areas, E2402 RR pays a uniform allowance of $1,504.41 per month for months 1 through 3, stepping down by 25 percent to $1,128.31 per month for months 4 through 13 4 19.
View chart data
| Category | Months 1–3 Rental Allowance | Months 4–13 Rental Allowance (75%) |
|---|---|---|
| E2402 Non-Rural (Median) | 829.21 | 621.91 |
| E2402 Rural (Uniform) | 1504.41 | 1128.31 |
| E2403 Statewide | 1352.58 | 1014.44 |
Monthly rental allowances step down by 25 percent in month four under 42 CFR § 414.229(b)(2); E2403 carries a statewide rate while E2402 has a rural differential.
- Amounts represent allowable monthly rental fees. E2402 non-rural displays the contiguous-state median ($829.21 M1–3 / $621.91 M4–13). E2403 displays the statewide rate ($1,352.58 M1–3 / $1,014.44 M4–13).
Source: CMS October 2026 DMEPOS Fee Schedule Public Use File (DME26-D) and 42 CFR § 414.229 — VEMERIX analysis, accessed October 2026.
- Durable Dressing Sets (HCPCS A6550) and Canisters (HCPCS A7000 NU): Dedicated wound dressings and exudate canisters are billed separately under DMEPOS 19. Under DME MAC Local Coverage Determination LCD L33821, Medicare covers up to a maximum of 15 dressing kits (A6550) per wound per month and up to 10 canister sets (A7000 NU) per month, with additional canisters allowed where documentation establishes drainage exceeding 90 ml per day 20. In the October 2026 file, non-rural allowances for A6550 range from $31.08 to $31.92 (median $31.35; rural uniform $33.70), while A7000 NU ranges from $9.83 to $10.93 (median $10.50; rural median $11.58, range $10.23–$11.58) 19.
- Match each state’s component amounts before summarizing a scenario: Our illustrative month uses one E2402 RR rental, 15 A6550 dressings and 10 A7000 NU canisters. It assumes those quantities for comparison; actual coverage and payment depend on the patient, use and applicable rules. Matching the same state and rural/non-rural column yields non-rural totals of $1,324.23–$1,457.19 (median $1,407.63) in months 1–3 and $1,137.16–$1,236.71 (median $1,199.40) in months 4–13. Rural totals are $2,112.21–$2,125.71 and $1,736.11–$1,749.61 respectively. Only the pump receives the 75% step-down; consumables retain their own units 4 19 20.
These are same-state scenario summaries. Adding the separately calculated minimum price for each component would instead produce $1,312.78 for the initial non-rural scenario, but those component minima need not belong to the same state. Likewise, $1,404.46 is the sum of component medians, not the median of the 49 state totals. A distributor should retain the state and category beside each component before calculating a quotation, and then check the actual claim-pricing ZIP code. The scenario excludes patient cost-sharing, geographic details within a state and other claim adjustments; it compares fee inputs rather than net receipts, clinical utilization or profit 19.
File layout and modifier checks
The public file has 53 non-rural and 53 rural state-level fields; this analysis uses 49 contiguous-state/DC pairs. Read the actual row’s HCPCS and both modifiers. A7000 NU and A7000 NU+KE are separate rows with different populated fields. Some statewide fees appear in non-rural columns with zero-filled rural fields, so interpret the zero using the row’s payment methodology. The record layout and CR 13990 explain the relevant conventions; the October 5 ZIP-code analysis discusses how to apply them without treating a state-level summary as a claim quote 19 21 22.
The October 1, 2026 DMEPOS Update (MM14619) and the Ophthalmic E2403 / A6614 Boundary
The October update adds E2403 and A6614 for an external ocular negative-pressure pump and its monthly supplies. The descriptor boundary matters even though E2403 sits beside E2402 numerically. The October 26 coding analysis provides the broader update history; the table below retains the product, payment-unit and scope distinctions needed here 5 6 19.
| Code | Descriptor | Payment category | Non-rural benchmark | Rural benchmark | FDA record context | Scope |
|---|---|---|---|---|---|---|
| E2402 RR | Negative pressure wound therapy electrical pump, stationary or portable 6 19 | Capped Rental (CR) / DME MAC (D) | $829.21 (Median, M1–3) / $621.91 (M4–13; M1–3 range $748.28–$881.94) 4 19 | $1,504.41 (M1–3) / $1,128.31 (M4–13; Uniform contiguous rural) 4 19 | OMP (21 CFR § 878.4780, Class II, 214 clearances through August 2026, 47 recall records across 25 events) 23 24 25 | Durable Wound NPWT Pump: Governed by LCD L33821; omitted from published Round 2028 categories 7 19 20. |
| E2403 RR | External ocular negative pressure pump, electric (Added Oct 1, 2026) 5 6 | Capped Rental (CR) / DME MAC (D) | $1,352.58 (M1–3) / $1,014.44 (M4–13; Uniform contiguous-state/DC values) 4 19 | Statewide Fee (no separate rural differential; zero-filled file cell) 19 21 | QQJ (21 CFR § 886.5000, Class II, DEN230055 & K252455) 26 27 28 | Ophthalmic Glaucoma Device: Do not bill for wound therapy; indicated for a defined subset of adult open-angle glaucoma patients 6 27. |
| A6550 | Wound care set, for negative pressure wound therapy electrical pump 6 19 | Supplies (SU) / DME MAC (D) | $31.35 (Median; Range $31.08–$31.92) 19 | $33.70 (Uniform contiguous rural) 19 | OMP (21 CFR § 878.4780) 23 24 | Wound Foam/Gauze Kits: Covered up to 15 sets per wound per month under LCD L33821 19 20. |
| A6614 NU | Supplies and accessories for external ocular negative pressure pump, per month 5 6 | Inexpensive & Routinely Purchased (IN) / (D) | $167.99 (Uniform non-rural fee; Ceiling $167.99 / Floor $142.79) 19 | Statewide Fee (no separate rural differential; zero-filled file cell) 19 21 | QQJ (21 CFR § 886.5000, Balance Ophthalmics goggle/tubing supplies) 26 27 | Ophthalmic Monthly Supplies: Supplies for the external ocular negative pressure pump 6 29 27. |
| A7000 NU | Canister, disposable, used with suction pump, each 6 19 | Inexpensive & Routinely Purchased (IN) / (D) | $10.50 (Median; Range $9.83–$10.93) 19 | $11.58 (Median; Range $10.23–$11.58) 19 | OMP (21 CFR § 878.4780) 23 24 | Wound Exudate Canister: Covered up to 10 canisters/month under LCD L33821 19 20. |
Program Integrity Landscape: Round 2028 Competitive Bidding, Master List Governance, and CERT Payment Error Analysis
Durable NPWT codes remain outside competitive bidding and active prior authorization lists checked for this report. Ordinary coverage, order, and clinical documentation rules continue to apply under Local Coverage Determination LCD L33821 20.
Scope and Implementation Timeline of the DMEPOS Competitive Bidding Program Round 2028
Durable NPWT is absent from the seven published Round 2028 RID categories. The RFB lists registration from December 1, 2026 to February 1, 2027 and bidding from January 5 to March 10, 2027. These dates help a supplier distinguish current NPWT planning from preparations for the included product categories. The October 26 report gives the categories, lead items and bid limits 7 8 30.
Federal Register Notice 91 FR 47972: Master List vs. Active Prior Authorization and F2F/WOPD Lists
E2402 is on the Master List but is not on the active Required Prior Authorization or F2F/WOPD lists checked for this report. Notice 91 FR 47972’s addition tables do not add durable NPWT to those active conditions. The notice phases selected orthosis prior-authorization requirements across October 28, 2026, January 26, 2027 and April 26, 2027; those selected-item changes should not be transferred to E2402. See the October 26 analysis for the distinction between potential eligibility and an active condition of payment 31 32 33.
CERT Improper Payment Trends and Documentation Defense Under LCD L33821
The 2024 and 2025 CERT reports give different annual samples and overlapping confidence intervals. The lower projected improper-payment dollar estimate measures estimated improper payments, not total NPWT spending. The October 12 review discusses the reports in more detail 34 35.
| Report Year | Sampling Period | Sampled NPWT Claims | Projected Improper Payments (USD) | Improper Payment Rate | 95% Confidence Interval |
|---|---|---|---|---|---|
| 2024 Report | July 1, 2022 – June 30, 2023 | 110 | $12,107,646 | 17.0% | 7.3%–26.6% |
| November 2025 Report | July 1, 2023 – June 30, 2024 | 45 | $6,504,562 | 11.1% | 1.3%–20.8% |
The CERT point estimate decreased from 17.0% in 2024 to 11.1% in 2025, but 95% confidence intervals overlap; these are survey-based payment error estimates, not audits of all claims.
- Independent annual sampling periods. The projected improper payment dollar amount is lower in 2025; this measures payment errors, not total Medicare NPWT program expenditures.
Source: CMS 2024 and 2025 Medicare Fee-for-Service Supplemental Improper Payment Data (CERT Tables G2 and K4) — VEMERIX analysis, accessed October 2026.
LCD L33821 and MLN compliance guidance require the applicable order and supporting clinical documentation. Record prior wound therapy tried or considered and ruled out where applicable, regular assessment/dressing supervision and monthly changes in dimensions and characteristics. Document length, width and depth; healing means improvement in surface area or depth. The wound-specific criteria differ: the 30-day chronicity phrase applies to the mixed-etiology ulcer category, rather than every listed wound 20 36.
The usual four-month calculation includes inpatient NPWT before home discharge. Earlier coverage-ending conditions still apply, including absent required assessment, adequate healing permitting discontinuation, no measurable healing over the preceding month or cessation of use. After the usual four months, individual consideration for one additional month at a time may be sought through appeals, with contemporaneous treating-practitioner records explaining special circumstances for each requested month 15; a rental fee schedule alone establishes no continued entitlement 20 36.
Technical Sponge Specification Governance: China YY/T 1872-2022 and FDA OMP Recall Event Recount
While reimbursement codes determine payment amounts, clinical safety and tender compliance depend on technical conformance. Engineering teams and procurement committees evaluating single-use NPWT dressing kits must verify specifications against the applicable standard and read recall records at event level.
OMP recall history: product records and event weighting
The retained FDA snapshot contains 47 product-level OMP recall records. Matching their recall numbers to the FDA device-recall API on November 6, 2026 identifies 25 distinct FDA recall-event identifiers (res_event_number) 25. All 47 records match; each event has one consistent coded root cause in this extract 25. The difference between product records and distinct events is consequential: one event affects eight listed products, and another affects six 25. Counting raw product rows gives those multi-product events disproportionate weight.
The earlier broader cohort contained 48 product records. First restricting it to OMP leaves 47 records; then grouping those records by FDA res_event_number yields 25 events. These are separate transformations. Product-record counts describe affected listed products, while event counts answer the narrower question of recorded actions. A multi-product event receives more weight in product-record percentages; each unit answers its stated descriptive question. 25.
View chart data
| Category | Distinct Recall Events |
|---|---|
| Device Design | 6 |
| Nonconforming Material/Component | 4 |
| No Marketing Application | 2 |
| Under Investigation by firm | 2 |
| Packaging change control | 1 |
| Labeling design | 1 |
| Process control | 1 |
| Error in labeling | 1 |
| Use error | 1 |
| Package design/selection | 1 |
| Packaging | 1 |
| Labeling Change Control | 1 |
| Packaging process control | 1 |
| Other | 1 |
| Unknown/Undetermined by firm | 1 |
47 OMP product records in the August 2026 snapshot group into 25 FDA events; a multi-product event has greater weight in product-record totals. Counts describe recall administration, not clinical failure rates.
- Grouped by FDA res_event_number. All 47 product records matched; coded categories represent FDA administrative classifications and do not measure failure rates or material-specific clinical risks.
Source: FDA Medical Device Recalls Database (Product Code OMP) — VEMERIX analysis, retained snapshot August 2026, recall-event identifiers matched November 6, 2026.
At event level, official root-cause categories include Device Design (six events), Nonconforming Material/Component (four), No Marketing Application (two), and Under Investigation by firm (two) 25. Eleven other named categories have one event each 25. The root cause code supplies an administrative category; foam chemistry, the affected component, and clinical consequences require investigating the individual recall reason and manufacturer response 25. Exposure counts and the total population of devices in active use are outside this extract 25. Consequently, this report makes no comparative failure-rate claim and does not use these records to justify a particular Chinese sponge requirement 25.
The practical use is to look up the affected manufacturer's exact product, lot number, recall reason, and corrective action before drawing a purchasing conclusion. Assigning a pump-design recall to a dressing material requires evidence about the actual affected component. Conversely, a material-specific standard can be relevant without any historical recall linkage. Those represent separate lines of technical evidence.
Technical Analysis of YY/T 1872-2022: Material Scope, Supplied State, and Acceptance Limits
The official standards record lists YY/T 1872-2022, 负压引流海绵 (published English title on the cover: Sponge for negative pressure wound therapy), as a current recommended medical-device industry standard 9 10. It was issued August 17, 2022 and implemented September 1, 2023 9 10. Recommended status (YY/T), destination registration rules, and tender contract terms have distinct legal roles in international procurement 9 10.
Clause 1 covers principally polyurethane (PU) and polyvinyl alcohol (PVA) negative-pressure drainage sponges, and explicitly excludes supporting NPWT equipment/accessories, drug-containing sponges, and sponges containing absorbable components 10. Clause 5.1 generally requires testing in the product's final supplied state unless otherwise specified 10. That condition is consequential when dry PVA is hydrated before testing; a test report must identify the supplied state and the applicable conditioning procedure, rather than treating all foam as interchangeable material 10.
| Procurement question | Clause and evidence | Intake implication |
|---|---|---|
| Which limits are manufacturer-declared? | Dimensions 4.2 and density 4.3 refer to the manufacturer’s range; methods 5.2 and 5.3 apply 10. | Request the actual declared range and a report identifying material, condition and method. A supplier’s declaration needs evidence showing the tested result falls within it. |
| Which mechanical limits are fixed? | Tensile strength 4.4 is at least 50 kPa; compression set 4.5 is at most 25%, using methods 5.4 and 5.5 10. | Keep the reported quantity and unit beside the acceptance criterion. A dimension or pore-size specification cannot replace these mechanical results. |
| What product state is tested? | Under 5.1, unless otherwise specified, tests use the product in its final state for use. Subsequent methods can prescribe specific conditioning 10. | Connect the tested sample to the supplied product and document any method-specific preparation. A raw-material result needs an explanation of its relevance to the final product. |
The October 19 evidence matrix covers the material-specific 4.6/4.7 water tests and 4.13/4.15 chemical provisions. In particular, the dry-mass water-content ratio in 5.7 uses g/g; preserving that denominator remains necessary when comparing reports 10.
For a buyer, a declared range and a fixed standard limit create different evidence requests. For dimensions, the approved product specification establishes the claimed range; the test report identifies what was measured and under which preparation. For tensile strength or compression set, a favorable marketing description still leaves the numerical result and prescribed method to verify. The finished-use-state rule adds another link: the report should make clear whether the sample represents what is supplied and whether the specific test calls for conditioning. These are editorial intake steps applying the cited clauses, not an invented universal certification process 10.
Likewise, a nominal pore size shown on a manufacturer's dressing catalog page is a product specification, not a national pore-size limit established by this standard 10 37. VEMERIX's published dressing specifications (400–600 µm pore size) and a manufacturing batch's conformity evidence serve different purposes 37. Buyers can compare configuration and labeling on public pages, then request controlled documents for the specific product SKU being considered 37.
Operational Verification Framework, Commercial Realities, and Client Portfolio Boundaries
To translate these payment, coding, and engineering findings into institutional operations, healthcare providers, distributors, and procurement teams should structure workflows around verified parameters.
A Hypothetical Catalog Change: Preventing Automated Cross-Specialty Misclassification
Consider a medical supply distributor importing the October 2026 DMEPOS quarterly update. An item adjacent to E2402 is newly listed, and an automated ERP text classifier proposes assigning it to the wound-care category based on the phrase "negative pressure". A manual descriptor check reveals the ocular indication in E2403 and the monthly ocular-supply description in A6614 5 6 29. The appropriate internal response is to route both entries to ophthalmic specialty review rather than derive a wound therapy quotation from numeric code proximity 6 23 27.
This scenario is a constructed operational example, not an observed customer deployment. The underlying descriptors and FDA labeling confirm the classification boundary, whereas the ERP routing protocol is an editorial recommendation. Catalog review processes should preserve effective dates and billing units when applying quarterly changes 5 19.
An Institutional Five-Step Verification Workflow for NPWT Intake
The following checks represent editorial recommendations. The cited sources supply the underlying payment, coding and documentation rules; the five-step workflow is an editorial aid requiring case-specific application 1 3 19 20 31 33 38.
| Verification Stage | Recommended Operational Check | Evidentiary Basis & Regulatory Boundary |
|---|---|---|
| 1. Care Setting Alignment | Identify care setting (Home Health TOB 032x vs. Physician Office vs. facility category) before selecting a payment rate. | Separate device amount (A9272 = $282.10), total non-facility application payment per session (97607 = $367.41), and durable pump rental (E2402 = $829.21 M1–3) represent distinct units 1 3 19. |
| 2. Code Descriptor Validation | Validate exact quarterly HCPCS long descriptors and labeled indications for newly added codes. | E2403 and A6614 are ophthalmic devices under Product Code QQJ; FDA clearance and Medicare coverage represent separate determinations 6 29 26 27. |
| 3. Program Integrity Checks | Verify date-stamped competitive bidding status and active required lists before budgeting prior authorization overhead. | E2402 is omitted from Round 2028 RID categories and remains outside active Required Prior Authorization and F2F/WOPD lists 7 8 31 32. |
| 4. Durable Home-Use DMEPOS: Medical Necessity & Orders | For the durable home-use DMEPOS branch, review the Standard Written Order (SWO) and records required under LCD L33821. Route disposable NPWT to the applicable home-health or professional-service rules; this LCD is not a universal disposable-NPWT condition. | Apply the order and wound-specific prior-therapy criteria, including measures tried or considered and ruled out where applicable; document regular assessment and monthly length, width and depth. The usual four months includes inpatient use; additional reimbursement uses one-month-at-a-time appeals with contemporaneous special-circumstance evidence 15 20 36 38. |
| 5. Technical Specification Intake | Match sponge test reports to material chemistry, supplied state, and declared manufacturer parameters. | Verify fixed limits (tensile >= 50 kPa, compression set <= 25%) and material-specific exemptions (PU exempt from 4.6 absorption and 4.7 water content) under YY/T 1872-2022 9 10. |
A defensible review outcome is a traceable audit trail: identifying the discrepancy, citing the authoritative primary source, logging affected quotations or catalog entries, and assigning responsibility for resolution. This structure provides greater governance value than an unverified compliance checkbox.
Boundaries of Public Manufacturer Specifications and Commercial Acquisition Realities
On its public technical product pages, VEMERIX publishes specifications for its Medical Vacuum Negative Pressure Wound Therapy Pump, including an operating pressure range of −50 to −450 mmHg adjustable in 10 mmHg increments, continuous and intermittent operating modes, and an operating noise level below 45 dB 39. These figures represent published manufacturer engineering specifications; clinical pressure selection must follow the device's Instructions for Use (IFU) and practitioner orders. Comparative clinical effectiveness across wound types requires separate clinical trial evidence 39.
VEMERIX's dressing documentation describes PU and PVA foam options with nominal pore sizes of 400–600 µm, complete with drape and suction tubing accessories 37. For procurement, match those portfolio configurations to the applicable lot-specific certificates and destination registrations 37. Procurement officers evaluating tenders must request the controlled conformity dossiers applicable to their specific jurisdiction rather than relying on commercial brochures 10 37.
Furthermore, public Medicare payment amounts cited throughout this report represent administrative statutory allowances, not commercial transaction prices 1 3 19. Commercial acquisition pricing depends on contracted volume, distribution tiers, and geographic logistics. Buyers and distributors can contact VEMERIX directly to request formal commercial quotations and product technical dossiers 37 39.
Conclusion
The central principle in NPWT financial governance is maintaining unit of account discipline. Home health separate device reimbursement ($282.10 under A9272), physician office application payment ($367.41 under 97607), and durable pump rental ($829.21 stepping down to $621.91 under E2402) answer entirely different financial questions. Financial models must pair every dollar figure with its care setting, effective date, billing unit, and applicable capped rental month.
For catalog governance, the October 1, 2026 DMEPOS update illustrates why code proximity cannot substitute for clinical descriptor verification. HCPCS E2403 and A6614 are external ocular devices indicated for lowering intraocular pressure in glaucoma; routing them into wound therapy categories can create a potential catalog or coding error. Concurrently, verifying that E2402 is omitted from Round 2028 competitive bidding and active prior authorization lists allows suppliers to allocate compliance resources where they are genuinely required: defending medical necessity documentation and monthly quantitative healing records under LCD L33821.
In technical sponge procurement, evaluation criteria must align with material chemistry and supplied state under YY/T 1872-2022. Polyurethane foam is excluded from water-absorption acceptance criteria, while wet polyvinyl alcohol foam requires dry-mass ratio accounting. For recall-history screening, choose the counting unit for the question and investigate the exact affected product, lot, reason and action. Neither product-record nor event counts alone establish comparative supplier safety. Procurement committees and distributors are encouraged to contact VEMERIX to review controlled technical files, sample configurations, and commercial procurement terms for their target markets.
Methodology and Data Boundaries
Payment calculations in this report are based on official CY 2026 CMS regulatory releases: HH PPS Transmittal 13488 (CR 14304), Physician Fee Schedule Final Rule CMS-1832-F (Relative Value File and Direct PE Inputs Public Use File), and the October 2026 DMEPOS Fee Schedule (DME26-D). Non-rural and rural fee summaries utilize the 49 contiguous-state and District of Columbia fee pairs. Composite monthly scenarios match each component within the same state and category column, then calculate the range and median across 49 contiguous-state/DC totals. The month 4–13 scenario applies 75% only to E2402 RR, rounds that pump amount to cents, and leaves consumables unchanged. The quantities 1 pump/15 dressings/10 canisters are illustrative; actual coverage and payment require the applicable rules 1 3 19 20.
The longitudinal Medicare Part B analysis reflects aggregate utilization and average payment data from the CMS Physician & Other Practitioners by Geography and Service dataset (2015–2024). Expenditure totals represent estimated payments derived by multiplying billed services by average Medicare payment amounts. Utilization data reflects billed service counts, not unique beneficiary counts, clinical efficacy, or direct causal proof of regulatory policy impact 17 18.
FDA regulatory counts reflect database snapshots accessed through openFDA endpoints. The 214 clearances under Product Code OMP span premarket notifications cleared through August 2026 24. The 47 OMP recall records were matched against the FDA device-recall API on November 6, 2026, and aggregated by distinct res_event_number into 25 recall events 25. Coded root causes reflect official administrative categories; their unit is a recorded recall event 25.
CERT data reflects projected improper payment rates from CMS Supplemental Improper Payment Data reports (2024 and 2025). The reported figures represent survey-based payment error estimates with overlapping 95 percent confidence intervals, not absolute measures of program spending or clinical fraud 34 35. Standards analyses are based on the retained official Chinese text of YY/T 1872-2022; clause interpretations provide procurement document review guidance and do not replace laboratory testing per validated protocols 9 10.
